Berry Genomics Co.,Ltd (SHE:000710)

China · Delayed Price · Currency is CNY

9.57

-0.42 (-4.20%)

Aug 11, 2026, 3:04 PM CST

Berry Genomics Co.,Ltd Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	922.27	929.82	1,078	1,151	1,368	1,422
Revenue Growth	-9.26%	-13.76%	-6.36%	-15.83%	-3.81%	-7.67%
Gross Profit	374.18	373.7	474.44	483.16	546.15	594.43
Operating Income	-189.49	-174.6	-119.47	-198.84	-125.56	-46.41
Net Income	-210.11	-196.84	-192.43	-427.2	-248.93	-110.82
Earnings Per Share	-0.59	-0.56	-0.54	-1.21	-0.81	-0.31
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023
China	815.37	942.53	1,032	1,238
Intersegment Elimination	-7.66	-	-	-
Overseas	122.1	135.63	119.76	129.79
Total	929.82	1,078	1,151	1,368

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	304.41	382.33	400.1	352.01	338.07	421.7
Total Debt	269.83	273.15	160.28	303.58	348.17	399.3
Net Cash (Debt)	34.59	109.18	239.82	48.43	-10.11	22.4
Net Cash Growth	-64.83%	-54.47%	395.21%	-	-	-91.81%
Net Cash Per Share	0.10	0.31	0.68	0.14	-0.03	0.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	13.57	70.61	87.97	111.01	21.18	94.03
Capital Expenditures	-76.52	-75.68	-56.75	-55.1	-73.31	-336.69
Free Cash Flow	-62.95	-5.08	31.22	55.91	-52.13	-242.66
Free Cash Flow Growth	-	-	-44.16%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	40.57%	40.19%	44.01%	41.96%	39.92%	41.80%
Operating Margin	-20.55%	-18.78%	-11.08%	-17.27%	-9.18%	-3.26%
Pretax Margin	-22.05%	-20.39%	-15.84%	-39.38%	-20.20%	-8.46%
Profit Margin	-22.78%	-21.17%	-17.85%	-37.10%	-18.20%	-7.79%
FCF Margin	-6.83%	-0.55%	2.90%	4.86%	-3.81%	-17.06%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Forward PE	-	39.28	39.28	39.28	39.28	51.73
P/FCF Ratio	-	-	95.70	72.85	-	-
PS Ratio	3.83	4.29	2.77	3.54	2.95	4.78